RSLS News and Press, ReShape Lifesciences Inc. From 03/22/23

SAN CLEMENTE, Calif., March 22, 2023 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced that it will report its financial results for the year ended December 31, 2022, including a ...

2023-03-20 10:29:09 ET Gainers: Lifecore Biomedical ( LFCR ) +41% . Connect Biopharma ( CNTB ) +27% . InMed Pharmaceuticals ( INM ) +21% . ReShape Lifesciences ( RSLS ) +21% . Bellerophon Therapeutics ( BLPH ) +15% . Losers...

2023-03-20 08:46:36 ET InMed Pharmaceuticals ( INM ) +29% . New York Community Bancorp ( NYCB ) +27% shines with 30% gain on multiple analyst upgrades amid Signature deal. PacWest Bancorp ( PACW ) +20% . ReShape Lifesciences  ( RSLS ) ...

SAN CLEMENTE, Calif., March 15, 2023 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that Paul F. Hickey, President and Chief Executive Officer, and Tom Stankovich, Chief Financ...

SAN CLEMENTE, Calif., Feb. 08, 2023 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced the closing of its upsized underwritten public offering of 1,275,000 units, with each unit consisting of ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Shutterstock Alset (NASDAQ: AEI ) stock is taking a beating on Monday after the company announced a proposed public stock offering. The public offering was initially announced on Friday and has since been...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: THICHA SATAPITANON / Shutterstock ReShape Lifesciences (NASDAQ: RSLS ) stock is falling hard on Monday as the company’s shares pull back from a rally on Friday. RSLS stock saw a massive gain on Fri...

ReShape Lifesciences ( NASDAQ: RSLS ) shares plummeted 62% premarket on Monday after the health solutions company priced its upsized $10.2M securities offering . The offering comprises 1,275,000 units, with each unit consisting of one share of common stock, or one pre-funded w...

SAN CLEMENTE, Calif., Feb. 06, 2023 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced the pricing of its upsized underwritten public offering of 1,275,000 units, with each unit consisting of ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips One of the biggest movers in today’s session,  Reshape Lifesciences  (NASDAQ: RSLS ) is absolutely skyrocketing. At the time of writing, RSLS stock has surged an impressive 150% in today’s session...